IVF Hartmann Cash And Equivalents vs. EBITDA

VBSN Stock  CHF 152.00  1.00  0.65%   
Considering IVF Hartmann's profitability and operating efficiency indicators, IVF Hartmann Holding may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess IVF Hartmann's ability to earn profits and add value for shareholders.
For IVF Hartmann profitability analysis, we use financial ratios and fundamental drivers that measure the ability of IVF Hartmann to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well IVF Hartmann Holding utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between IVF Hartmann's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of IVF Hartmann Holding over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Please note, there is a significant difference between IVF Hartmann's value and its price as these two are different measures arrived at by different means. Investors typically determine if IVF Hartmann is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IVF Hartmann's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

IVF Hartmann Holding EBITDA vs. Cash And Equivalents Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining IVF Hartmann's current stock value. Our valuation model uses many indicators to compare IVF Hartmann value to that of its competitors to determine the firm's financial worth.
IVF Hartmann Holding is rated first in cash and equivalents category among its peers. It is rated first in ebitda category among its peers totaling about  0.45  of EBITDA per Cash And Equivalents. The ratio of Cash And Equivalents to EBITDA for IVF Hartmann Holding is roughly  2.21 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IVF Hartmann's earnings, one of the primary drivers of an investment's value.

IVF EBITDA vs. Cash And Equivalents

Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

IVF Hartmann

Cash

 = 

Bank Deposits

+

Liquidities

 = 
29.35 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

IVF Hartmann

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
13.27 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

IVF EBITDA Comparison

IVF Hartmann is currently under evaluation in ebitda category among its peers.

IVF Hartmann Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in IVF Hartmann, profitability is also one of the essential criteria for including it into their portfolios because, without profit, IVF Hartmann will eventually generate negative long term returns. The profitability progress is the general direction of IVF Hartmann's change in net profit over the period of time. It can combine multiple indicators of IVF Hartmann, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company was founded in 1874 and is headquartered in Neuhausen am Rheinfall, Switzerland. IVF HARTMANN operates under Medical Instruments Supplies classification in Switzerland and is traded on Switzerland Exchange. It employs 323 people.

IVF Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on IVF Hartmann. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of IVF Hartmann position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the IVF Hartmann's important profitability drivers and their relationship over time.

Use IVF Hartmann in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IVF Hartmann position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IVF Hartmann will appreciate offsetting losses from the drop in the long position's value.

IVF Hartmann Pair Trading

IVF Hartmann Holding Pair Trading Analysis

The ability to find closely correlated positions to IVF Hartmann could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IVF Hartmann when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IVF Hartmann - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling IVF Hartmann Holding to buy it.
The correlation of IVF Hartmann is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IVF Hartmann moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if IVF Hartmann Holding moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IVF Hartmann can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your IVF Hartmann position

In addition to having IVF Hartmann in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Preferred Stock ETFs Thematic Idea Now

Preferred Stock ETFs
Preferred Stock ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Preferred Stock ETFs theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Preferred Stock ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for IVF Stock Analysis

When running IVF Hartmann's price analysis, check to measure IVF Hartmann's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IVF Hartmann is operating at the current time. Most of IVF Hartmann's value examination focuses on studying past and present price action to predict the probability of IVF Hartmann's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IVF Hartmann's price. Additionally, you may evaluate how the addition of IVF Hartmann to your portfolios can decrease your overall portfolio volatility.